%e9%92%88%e5%88%ba%e8%9d%b6%e8%85%ad%e7%a5%9e%e7%bb%8f%e8%8a%82%e6%b2%bb%e7%96%97%e4%b8%ad%e9%87%8d%e5%ba%a6%e5%8f%98%e5%ba%94%e6%80%a7%e9%bc%bb%e7%82%8e.pdf...

20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3 209

allergic rhinitis, AR 2012 8 2013 11 42 AR 2 21 1 4 3 4 2 1 4 total nasal symptoms score, TNSStotal non-nasal symptom score, TNNSSrhinoconjunctivitis quality of life questionnaire, RQLQ 1 TNSSTNNSS RQLQ [5.04.06.0 9.07.010.01.01.01.5 3.03.03.044.035.550.0 60.053.575.06.05.58.0 10.08.510.12.02.03.0 3.003.03.050.045.558.0 43.027.048.0]P 0.01 2 TNSSTNNSS RQLQ P 0.01 4 TNSS[2.01.03.0 3.02.04.5]TNNSS[1.00.01.0 2.02.03.0]RQLQ[24.019.029.0 43.027.048.5]P 0.01 AR Acupuncture at the sphenopalatine ganglion for the treatment of patients with moderate-to-severe allergic rhinitis Chen Luquan*, Wang Kuiji, Tan Yi, Zhang Yanchao, Yang Wei, Li Xinwu, Fang Gaoli, Wang Chengxiang. *Department of Acupuncture, Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China Corresponding author: Wang Chengxiang, Department of Respiratory Medicine, Beijing Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China; Email: wang601@sina.vip.com

Abstract Objective To assess the clinical efficacy of acupuncture at the sphenopalatine ganglion for the treatment of patients with moderate to severe allergic rhinitis. Methods 42 cases of moderate to severe allergic rhinitis patients in Otorhinolaryngology clinic of Tongren Hospital between August 2012 to November 2013 were randomized into a treatment group and a control group. The treatment group was treated by acupuncturing sphenopalatine ganglion, once per week, altogether 4 times. The control group was treated by acupuncturing Fengchi (GB20), Baihui (GV20), Yingxiang (GV29), Shangxing (GV23),Taiyang (EX-HN5), Quchi (LI11) and Zusanli (ST36) was used in the control group, 3 times per week for 4 weeks. The changes of the Total Nasal Symptoms Score (TNSS) and the Total Non-Nasal Symptom Score (TNNSS) were evaluated before and after treatment. The Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ) was used to evaluate DOI: 10.3760/cma.j.issn.1673-4246.2015.03.005

2014BBYJ01JJ2013-26TRYY-KYJJ-2014-037 100730 100011 100070 Email: wang601@sina.vip.com

210 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3

the quality of life. Results One week after treatment, the scores of TNSS, TNNSS and RQLQ in both groups were significantly improved than before the treatment (treatment group: 5.0[4.0, 6.0] vs. 9.0[7.0, 10.0], 1.0[1.0, 1.5] vs. 3.0[3.0, 3.0], 44.0[35.5, 50.0] vs. 60.0[53.575.0]; control group: 6.0[5.5, 8.0] vs. 10.0[8.5, 10.1], 2.0[2.0, 3.0] vs. 3.00[3.0, 3.0], 50.0[45.5, 58.0] vs. 43.0[27.0, 48.0]; all P

20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3 211

13 mm 20 min 1 3 4 12 1.3 TNSS 4 5 0 1 23 4 TNSS total non-nasal symptom score, TNNSS0 1 TNNSS [7]rhinoconjunctivitis quality of life questionnaire, RQLQ7 24 0 1 2 3 4 5 6 RQLQ 2 1 4 1 1.4 SPSS 13.0 sx

MQ1Q3[8]P0.05

2 2 45 3 2 1 2.1 2 1 2 TNSSTNNSSRQLQ P0.01 1 4 P0.01 1 2.2 1 24 h 24 h 3 d

3 AR

AR

1 2 TNSSTNNSSRQLQ [M(Q1Q3)]

TNSS TNNSS RQLQ 23 9.0(7.0,10.0) 3.0(3.0,3.0) 60.0(53.5,75.0) 1 21 5.0(4.0, 6.0)a 1.0(1.0,1.5)a 44.0(35.5,50.0)a 4 21 2.0(3.0, 1.0)ab 1.0(1.0,0.0)ab 24.0(29.0,19.0)ab 22 10.0(8.5,10.1) 3.0(3.0,3.0) 43.0(27.0,48.0) 1 21 6.0(5.5, 8.0)a 2.0(2.0,3.0)a 50.0(45.5,58.0)a 4 21 3.0(2.0, 4.5)a 2.0(2.0,3.0)a 43.0(27.0,48.5)a

TNSSTNNSSRQLQaP0.01bP0.01

212 20153373 Int J Trad Chin Med, March 2015, Vol. 37, No.3

[9][10][11] 4 1

1 4 1 3 20 min

1 Skoner DP. Allergic rhinitis:definition,epidemiology,path-

ophysiologu,detection,and diagnose[J]. J Allergy Clin Immunol, 2001,108(Suppl 1):S2-S8.

2 ,. [J]. ,2012,31(8):631-633.

3 Bousquet J,Khaltaev N,Cruz AA,et al. Allergic Rhinitis and its Impact on Asthma(ARIA)2008 update(in collaboration with the World Health Organization,GA(2)LEN and Allergen)[J]. Allergy,2008,63(86):8-160.

4 Bousquet J,Combesure C,Neukirch F,et al. Visualanalog scales can assess the severity of rhinitis graded according to ARIA guidelines[J]. Allergy,2007,62(4):367-372.

5 ,,. [J]. ,1995,12(1):6-8.

6 . [J]. ,2009,25(1):1-3.

7 Juniper EF. Measuring health-related quality of life in rhinitis[J]. J Allergy Clin Immunol,1997,99(2):S742-S749.

8 ,. [J]. ,2005,13(5):397-399.

9 ,. [J]. ,1997,32(3):163-166.

10 . 3[J]. ,2011,25(5):193-196.

11 ,,,. 3[J]. ,2013,35(7): 586-589.

2014-10-16